Title : Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy.

Pub. Date : 2014 Aug

PMID : 25083297






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy. Irinotecan ATP binding cassette subfamily G member 2 (Junior blood group) Homo sapiens
2 Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy. Irinotecan ATP binding cassette subfamily G member 2 (Junior blood group) Homo sapiens
3 We examined the expression of BCRP and ERCC1 in patients with esophageal cancer and correlated it with survival in patients receiving irinotecan and cisplatin based chemotherapy. Irinotecan ATP binding cassette subfamily G member 2 (Junior blood group) Homo sapiens